[{"address1": "2 Burlington Woods Drive", "address2": "Suite 100", "city": "Burlington", "state": "MA", "zip": "01803", "country": "United States", "phone": "781 552 4452", "website": "https://www.bonebiologics.com", "industry": "Medical Devices", "sector": "Healthcare", "longBusinessSummary": "Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jeffrey  Frelick", "age": 57, "title": "CEO & President", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 325000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Deina H. Walsh", "age": 59, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 212500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shun'ichi  Kuroda", "title": "Co-Founder & Member of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.69, "open": 1.68, "dayLow": 1.56, "dayHigh": 1.88, "regularMarketPreviousClose": 1.69, "regularMarketOpen": 1.68, "regularMarketDayLow": 1.56, "regularMarketDayHigh": 1.88, "beta": 0.67, "trailingPE": 0.0865493, "forwardPE": -0.35549587, "volume": 258694, "regularMarketVolume": 258694, "averageVolume": 2163496, "averageVolume10days": 7664250, "averageDailyVolume10Day": 7664250, "bid": 1.69, "ask": 1.74, "bidSize": 100, "askSize": 100, "marketCap": 1893503, "fiftyTwoWeekLow": 1.0, "fiftyTwoWeekHigh": 10.64, "fiftyDayAverage": 1.51122, "twoHundredDayAverage": 2.665695, "currency": "USD", "enterpriseValue": -1367807, "floatShares": 1007817, "sharesOutstanding": 1100490, "sharesShort": 5316, "sharesShortPriorMonth": 21746, "sharesShortPreviousMonthDate": 1718323200, "dateShortInterest": 1721001600, "sharesPercentSharesOut": 0.0047999998, "heldPercentInsiders": 0.08306, "heldPercentInstitutions": 0.03963, "shortRatio": 0.05, "shortPercentOfFloat": 0.005, "bookValue": 5.44, "priceToBook": 0.31628677, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -6104802, "trailingEps": 19.88, "forwardEps": -4.84, "lastSplitFactor": "1:2", "lastSplitDate": 1634083200, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "BBLG", "underlyingSymbol": "BBLG", "shortName": "Bone Biologics Corp", "longName": "Bone Biologics Corporation", "firstTradeDateEpochUtc": 1634131800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ef723e6d-c4c0-3645-8eff-e1206a869bb4", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.7206, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 3227634, "totalCashPerShare": 2.933, "quickRatio": 19.606, "currentRatio": 23.323, "returnOnAssets": -0.84535, "returnOnEquity": -1.8937399, "freeCashflow": -8192907, "operatingCashflow": -9509322, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-08-12"}]